New from BBI Solutions, Cardiff, Wales, UK, is a new grade of flavin adenine dinucleotide-dependent glucose dehydrogenase (FAD-GDH) for blood glucose monitoring. Offering reduced xylose interference, the enzyme has a higher specificity to glucose and reduced cross-reactivity with other sugars, thereby increasing test accuracy. Useful for both end-users and manufacturers of biosensor technology, the higher reactivity of the enzyme provides a faster signal, and its improved pH and stability enhances reliable strip performance. Increased reactivity may also produce cost-savings, as fewer units of enzyme are needed in each strip. The company introduced the first grade of the recombinant FAD-GDH in 2013. For more information or to request an evaluation sample, visit BBI Solutions.